Overview

High-Intensity Inpatient MDMA-Assisted Psychotherapy for PTSD

Status:
ENROLLING_BY_INVITATION
Trial end date:
2027-01-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the feasibility, safety and efficacy of high-intensity inpatient MDMA-assisted psychotherapy for treatment-refractory posttraumatic stress disorder.
Phase:
PHASE2
Details
Lead Sponsor:
ARQ National Psychotrauma Centre
Collaborator:
Leiden University Medical Center